Study shows prediabetes remission does not always require weight loss
New evidence shows that restoring normal glucose regulation can shield against diabetes even without weight loss, reshaping prevention…
New medication lowered hard-to-control high blood pressure in people with chronic kidney disease
Research Highlights:
Results from the FigHTN Phase 2 clinical trial showed baxdrostat, a new medication that inhibits…
Estrogen supports kidney regeneration and protects women from chronic disease
A new study in mice provides insights into why females in their reproductive years appear to be relatively…
Adding aspirin raises cardiovascular events in high-risk CCS patients on anticoagulants
Adding aspirin increased the risk of cardiovascular events, death and major bleeding in high-risk patients with chronic coronary…
Lubiprostone shows promise in slowing kidney disease progression
Chronic kidney disease (CKD) is a major health issue worldwide. Many patients end up requiring regular dialysis to…
Nocturnal hypoxemic burden is associated with worsening prognosis of chronic kidney disease in patients with type 2 diabetes | Cardiovascular Diabetology
Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, et al. Global, regional, and national…
Continuous Metabolic Syndrome Severity Score Linked With CKD Risk
A patient’s continuous metabolic syndrome severity score (cMetS-S) could help predict chronic kidney disease (CKD) even if other…
Elevated Risk of Kidney Disease Not Linked to Cannabis Use
Image | adobe.stock/Aliaksandr Marko A recent study published in Cannabis and Cannabinoid Research, further examined the health implications…
Chronic kidney disease related to Loa loa microfilaremia in a rural area of the Republic of Congo: a population-based cross-sectional study | Infectious Diseases of Poverty
Study area and population This cross-sectional study, nested within a cohort study, was conducted in May–June 2022 and…
Somatic mutations drive vascular aging and muscle weakness over time
Two new studies from Karolinska Institutet in Sweden have investigated how mutations that occur in muscles and blood…
Health Canada approves Ozempic® to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease
Ozempic® is the first-and-only medication indicated for both the once-weekly treatment of adult patients with type 2 diabetes…